$1.2 Billion From U.S. to Drugmaker to Pursue Coronavirus Vaccine squib

The Trump administration announced a grant to AstraZeneca, which has licensed a potential vaccine that is in trials by Oxford University.
Scroll for more
Continue reading on New York Times...
Tags: